Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Sandra Zarmer

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5007669572; NIH RePORTER profile ID 15581092. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 grant · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Context-specific genetic interaction mapping reveals combinatorial KRAS/FGFR dependence in pancreatic cancer Co-author DOI 10.64898/2026.09.24.754062↗
  2. New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular Subtype. Co-author DOI 10.1002/jso.28044↗
  3. Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer. Co-author DOI 10.1002/jso.27582↗

Grants 1

  1. Identifying targets for combination therapy with FOLFIRINOX and investigating cell polarity loss as a potential driver of invasion in basal-like PDAC F31CA257224↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jen Jen Yeh · 3 shared papers, 2024–2026 · strength 0.65
  2. Hannah E. Trembath · 2 shared papers, 2024–2025 · strength 0.44
  3. Joseph F. Kearney · 2 shared papers, 2024–2025 · strength 0.44
  4. William R Sellers · 1 shared paper, 2026 · strength 0.22
  5. Richard Y. Ebright · 1 shared paper, 2026 · strength 0.22
  6. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.22
  7. James M. Cleary · 1 shared paper, 2026 · strength 0.22
  8. Yi Xu · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.